Sairam Parthasarathy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sairam Parthasarathy has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Combs
Department of Pediatrics, University of Arizona, Tucson, AZ
5 shared publications - Michael A. Grandner
Sleep and Health Research Program, Department of Psychiatry, University of Arizona College of Medicine – Tucson , Tucson, AZ
3 shared publications - Biren B. Kamdar
Biren B. Kamdar is an associate professor, Division of Pulmonary, Critical Care, and Sleep Medicine, University of California, San Diego, and a staff physician, Pulmonary and Critical Care, VA San Diego Healthcare System, La Jolla, California
2 shared publications - Melissa P. Knauert
Department of Internal Medicine, Yale University School of Medicine
2 shared publications - Phyllis C. Zee
Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL
2 shared publications Aaron Fernandes
Center for Sleep Disorders and Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Arizona, Tucson, AZ
1 shared publication
Latest Publications
- Open Access
Improvements in patient-reported outcomes after neuromuscular electrical stimulation therapy for snoring and mild sleep apnea
Objectives: Neuromuscular electrical stimulation (NMES) offers alternative options to patients with Obstructive Sleep Apnea (OSA) unable to tolerate first line treatment. Randomized controlled trial data suggest efficacy of NMES treatment in improving OSA outcomes, snoring and sleepiness; however, no study to our knowledge has examined the effects on a range of daytime patient reported outcomes in a large real-world sample. Methods: This report presents clinical data from 472 patients completing NMES treatment. Bayesian linear mixed models were used to analyze pre-to-post treatment changes in mood (PHQ8), sleep disturbance (PROMIS-SD-4a), sleep related impairment (PROMIS-SRI-4a), and functioning (FOSQ), whilst controlling for key covariates. Posterior probabilities were calculated to estimate the probability of a change in symptoms (P(effect > 0)) and probability of exceeding a minimal clinically important difference (P(effect > MCID)). Results: The posterior probabilities of an improvement in scores in sleep disturbance (mean change −6.1, 94% HDI: −3.8 to −8.5) and sleep-related impairment (mean change −10.0, 94% HDI: −5.4 to −14), depression (mean change −3.5, 94% HDI: −1.7 to −5.2), at posttreatment were greatest and varied between 99.8 to 100%. Probability of change in functioning was low (60.9% chance of improvement). These effects remained when controlling for age, gender, treatment adherence, mean intensity and variance in intensity. Probabilities for MCI change for mood, sleep disturbance and sleep-related impairment were high (86-91%). Conclusions: The results from this report highlight the potential impact NMES therapy has on patient reported outcomes. These findings are in support of prior randomized placebo-controlled data and several observational cohort studies for NMES as treatment for mild OSA.
Open AccessImprovements in patient-reported outcomes after neuromuscular electrical stimulation therapy for snoring and mild sleep apnea
Objectives: Neuromuscular electrical stimulation (NMES) offers alternative options to patients with Obstructive Sleep Apnea (OSA) unable to tolerate first line treatment. Randomized controlled trial data suggest efficacy of NMES treatment in improving OSA outcomes, snoring and sleepiness; however, no study to our knowledge has examined the effects on a range of daytime patient reported outcomes in a large real-world sample. Methods: This report presents clinical data from 472 patients completing NMES treatment. Bayesian linear mixed models were used to analyze pre-to-post treatment changes in mood (PHQ8), sleep disturbance (PROMIS-SD-4a), sleep related impairment (PROMIS-SRI-4a), and functioning (FOSQ), whilst controlling for key covariates. Posterior probabilities were calculated to estimate the probability of a change in symptoms (P(effect > 0)) and probability of exceeding a minimal clinically important difference (P(effect > MCID)). Results: The posterior probabilities of an improvement in scores in sleep disturbance (mean change −6.1, 94% HDI: −3.8 to −8.5) and sleep-related impairment (mean change −10.0, 94% HDI: −5.4 to −14), depression (mean change −3.5, 94% HDI: −1.7 to −5.2), at posttreatment were greatest and varied between 99.8 to 100%. Probability of change in functioning was low (60.9% chance of improvement). These effects remained when controlling for age, gender, treatment adherence, mean intensity and variance in intensity. Probabilities for MCI change for mood, sleep disturbance and sleep-related impairment were high (86-91%). Conclusions: The results from this report highlight the potential impact NMES therapy has on patient reported outcomes. These findings are in support of prior randomized placebo-controlled data and several observational cohort studies for NMES as treatment for mild OSA.
- Open Access
- 21 May 2026
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 212 (9) , 2131-2134
Implementing sleep apnea care to improve Positive Airway Pressure adherence here and across the pond
- 21 May 2026
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 212 (9) , 2131-2134
Open AccessImplementing sleep apnea care to improve Positive Airway Pressure adherence here and across the pond
- Open Access
- 1 June 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (6) , 918-921
Coming Full Circle with Preventive Pulmonary Practice: The American Thoracic Society Vaccine Initiative
- 1 June 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (6) , 918-921
Open AccessComing Full Circle with Preventive Pulmonary Practice: The American Thoracic Society Vaccine Initiative
- 1 February 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (2) , 248-257
Peer-Driven Intervention for Care Coordination and Adherence Promotion for Obstructive Sleep Apnea: A Randomized, Parallel-Group Clinical Trial
Rationale: Obstructive sleep apnea (OSA) is a common condition that is usually treated by continuous positive airway pressure (CPAP) therapy, but poor adherence is common and is associated with worse patient outcomes and experiences. Patient satisfaction is increasingly adopted as a quality indicator by healthcare systems. Objectives: We tested the hypothesis that peer-driven intervention effected through an interactive voice response (IVR) system leads to better patient satisfaction (primary outcome), care coordination, and CPAP adherence than active control. Methods: We performed a 6-month randomized, parallel-group, controlled trial with CPAP-naive patients recruited from four centers and CPAP-adherent patients who were trained to be mentors delivering support through an IVR system. Measurements and Main Results: In 263 patients, intention-to-treat analysis of global satisfaction for sleep-specific services was better in the intervention group (4.57 ± 0.71 Likert scale score; mean ± SD) than in the active-control group (4.10 ± 1.13; P < 0.001). CPAP adherence was greater in the intervention group (4.5 ± 0.2 h/night; 62.0% ± 3.0% of nights >4 h use) versus the active-control group (3.7 ± 0.2 h/night; 51.4% ± 3.0% of nights >4 h use; P = 0.014 and P = 0.023). When compared with the active-control group, the Patient Assessment of Chronic Illness Care rating was moderately increased by an adjusted difference of 0.33 ± 0.12 (P = 0.009), Consumer Assessment of Healthcare Provider and Systems rating was not different (adjusted difference, 0.46 ± 0.26; P = 0.076), and Client Perception of Coordination Questionnaire was mildly better in the intervention group (adjusted difference, 0.15 ± 0.07; P = 0.035). Conclusions: Patient satisfaction with care delivery, CPAP adherence, and care coordination were improved by peer-driven intervention through an IVR system. New payor policies compensating peer support may enable implementation of this approach. Clinical trial registered with www.clinicaltrials.gov (NCT02056002).
- 1 February 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (2) , 248-257
Peer-Driven Intervention for Care Coordination and Adherence Promotion for Obstructive Sleep Apnea: A Randomized, Parallel-Group Clinical Trial
Rationale: Obstructive sleep apnea (OSA) is a common condition that is usually treated by continuous positive airway pressure (CPAP) therapy, but poor adherence is common and is associated with worse patient outcomes and experiences. Patient satisfaction is increasingly adopted as a quality indicator by healthcare systems. Objectives: We tested the hypothesis that peer-driven intervention effected through an interactive voice response (IVR) system leads to better patient satisfaction (primary outcome), care coordination, and CPAP adherence than active control. Methods: We performed a 6-month randomized, parallel-group, controlled trial with CPAP-naive patients recruited from four centers and CPAP-adherent patients who were trained to be mentors delivering support through an IVR system. Measurements and Main Results: In 263 patients, intention-to-treat analysis of global satisfaction for sleep-specific services was better in the intervention group (4.57 ± 0.71 Likert scale score; mean ± SD) than in the active-control group (4.10 ± 1.13; P < 0.001). CPAP adherence was greater in the intervention group (4.5 ± 0.2 h/night; 62.0% ± 3.0% of nights >4 h use) versus the active-control group (3.7 ± 0.2 h/night; 51.4% ± 3.0% of nights >4 h use; P = 0.014 and P = 0.023). When compared with the active-control group, the Patient Assessment of Chronic Illness Care rating was moderately increased by an adjusted difference of 0.33 ± 0.12 (P = 0.009), Consumer Assessment of Healthcare Provider and Systems rating was not different (adjusted difference, 0.46 ± 0.26; P = 0.076), and Client Perception of Coordination Questionnaire was mildly better in the intervention group (adjusted difference, 0.15 ± 0.07; P = 0.035). Conclusions: Patient satisfaction with care delivery, CPAP adherence, and care coordination were improved by peer-driven intervention through an IVR system. New payor policies compensating peer support may enable implementation of this approach. Clinical trial registered with www.clinicaltrials.gov (NCT02056002).
- Open Access
- 1 January 2024
- Published by American Public Health Association in American Journal of Public Health
- Vol. 114 (S1) , S37-S40
Temporal Changes in Vaccine-Specific Willingness Across Race/Ethnicity Following Serious Adverse Event Reports
- 1 January 2024
- Published by American Public Health Association in American Journal of Public Health
- Vol. 114 (S1) , S37-S40
Open AccessTemporal Changes in Vaccine-Specific Willingness Across Race/Ethnicity Following Serious Adverse Event Reports
- Top Cited PapersOpen Access
- 1 April 2023
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 207 (7) , e49-e68
Causes, Consequences, and Treatments of Sleep and Circadian Disruption in the ICU: An Official American Thoracic Society Research Statement
Background: Sleep and circadian disruption (SCD) is common and severe in the ICU. On the basis of rigorous evidence in non-ICU populations and emerging evidence in ICU populations, SCD is likely to have a profound negative impact on patient outcomes. Thus, it is urgent that we establish research priorities to advance understanding of ICU SCD. Methods: We convened a multidisciplinary group with relevant expertise to participate in an American Thoracic Society Workshop. Workshop objectives included identifying ICU SCD subtopics of interest, key knowledge gaps, and research priorities. Members attended remote sessions from March to November 2021. Recorded presentations were prepared and viewed by members before Workshop sessions. Workshop discussion focused on key gaps and related research priorities. The priorities listed herein were selected on the basis of rank as established by a series of anonymous surveys. Results: We identified the following research priorities: establish an ICU SCD definition, further develop rigorous and feasible ICU SCD measures, test associations between ICU SCD domains and outcomes, promote the inclusion of mechanistic and patient-centered outcomes within large clinical studies, leverage implementation science strategies to maximize intervention fidelity and sustainability, and collaborate among investigators to harmonize methods and promote multisite investigation. Conclusions: ICU SCD is a complex and compelling potential target for improving ICU outcomes. Given the influence on all other research priorities, further development of rigorous, feasible ICU SCD measurement is a key next step in advancing the field.
- 1 April 2023
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 207 (7) , e49-e68
Top Cited PapersOpen AccessCauses, Consequences, and Treatments of Sleep and Circadian Disruption in the ICU: An Official American Thoracic Society Research Statement
Background: Sleep and circadian disruption (SCD) is common and severe in the ICU. On the basis of rigorous evidence in non-ICU populations and emerging evidence in ICU populations, SCD is likely to have a profound negative impact on patient outcomes. Thus, it is urgent that we establish research priorities to advance understanding of ICU SCD. Methods: We convened a multidisciplinary group with relevant expertise to participate in an American Thoracic Society Workshop. Workshop objectives included identifying ICU SCD subtopics of interest, key knowledge gaps, and research priorities. Members attended remote sessions from March to November 2021. Recorded presentations were prepared and viewed by members before Workshop sessions. Workshop discussion focused on key gaps and related research priorities. The priorities listed herein were selected on the basis of rank as established by a series of anonymous surveys. Results: We identified the following research priorities: establish an ICU SCD definition, further develop rigorous and feasible ICU SCD measures, test associations between ICU SCD domains and outcomes, promote the inclusion of mechanistic and patient-centered outcomes within large clinical studies, leverage implementation science strategies to maximize intervention fidelity and sustainability, and collaborate among investigators to harmonize methods and promote multisite investigation. Conclusions: ICU SCD is a complex and compelling potential target for improving ICU outcomes. Given the influence on all other research priorities, further development of rigorous, feasible ICU SCD measurement is a key next step in advancing the field.
- Open Access
- 1 February 2023
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 207 (3) , 244-254
Moving toward Equitable Care for Sleep Apnea in the United States: Positive Airway Pressure Adherence Thresholds: An Official American Thoracic Society Policy Statement
Background: Positive airway pressure (PAP) is a highly effective treatment for obstructive sleep apnea (OSA), but adherence limits its efficacy. In addition, coverage of PAP by CMS (Centers for Medicare & Medicaid Services) and other insurers in the United States depends on adherence. This leaves many beneficiaries without PAP, disproportionally impacting non-white and low socioeconomic position patients with OSA and exacerbating sleep health disparities. Methods: An inter-professional, multidisciplinary, international committee with various stakeholders was formed. Three working groups (the historical policy origins, impact of current policy, and international PAP coverage models) met and performed literature reviews and discussions. Using surveys and an iterative discussion-based consensus process, the policy statement recommendations were created. Results: In this position paper, we advocate for policy change to CMS PAP coverage requirements to reduce inequities and align with patient-centered goals. We specifically call for eradicating repeat polysomnography, eliminating the 4-hour rule, and focusing on patient-oriented outcomes such as improved sleepiness and sleep quality. Conclusions: Modifications to the current policies for PAP insurance coverage could improve health disparities.
- 1 February 2023
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 207 (3) , 244-254
Open AccessMoving toward Equitable Care for Sleep Apnea in the United States: Positive Airway Pressure Adherence Thresholds: An Official American Thoracic Society Policy Statement
Background: Positive airway pressure (PAP) is a highly effective treatment for obstructive sleep apnea (OSA), but adherence limits its efficacy. In addition, coverage of PAP by CMS (Centers for Medicare & Medicaid Services) and other insurers in the United States depends on adherence. This leaves many beneficiaries without PAP, disproportionally impacting non-white and low socioeconomic position patients with OSA and exacerbating sleep health disparities. Methods: An inter-professional, multidisciplinary, international committee with various stakeholders was formed. Three working groups (the historical policy origins, impact of current policy, and international PAP coverage models) met and performed literature reviews and discussions. Using surveys and an iterative discussion-based consensus process, the policy statement recommendations were created. Results: In this position paper, we advocate for policy change to CMS PAP coverage requirements to reduce inequities and align with patient-centered goals. We specifically call for eradicating repeat polysomnography, eliminating the 4-hour rule, and focusing on patient-oriented outcomes such as improved sleepiness and sleep quality. Conclusions: Modifications to the current policies for PAP insurance coverage could improve health disparities.
- 13 September 2022
- Published by Springer Nature in Current Sleep Medicine Reports
- Vol. 8 (4) , 114-123
Circadian Rhythm and Pain: a Review of Current Research and Future Implications
- 13 September 2022
- Published by Springer Nature in Current Sleep Medicine Reports
- Vol. 8 (4) , 114-123
Circadian Rhythm and Pain: a Review of Current Research and Future Implications
- Open Access
- 25 May 2022
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 45 (Supplement) , A331
0760 Excessive daytime sleepiness, positive airway pressure, and patient satisfaction with multiple aspects of care in a real-world population with obstructive sleep apnea
Excessive daytime sleepiness (EDS) is common in patients with obstructive sleep apnea (OSA) and can persist despite use of positive airway pressure (PAP) therapy. These analyses assessed relationships between EDS, PAP use, and patient satisfaction across several aspects of OSA care in a real-world population with OSA. US residents (aged ≥18 years, self-reported physician OSA diagnosis [1/1/2015–3/31/2020]) completed a survey in Evidation Health’s Achievement app assessing Epworth Sleepiness Scale (ESS), PAP usage, and satisfaction with care. Self-reported PAP use was categorized as nonuse, nonadherent (<4 h/night; 10). PAP use was: nonuse (n=700), nonadherent (n=153), or adherent (n=1436; intermediate n=225, high n=1211). Within these subgroups, the proportions (95% CI) with EDS were: nonuse (47% [43.7–51.1]), nonadherent (52% [44.4–60.2]), intermediate (53% [46.4–59.4]), and highly adherent (36% [33.7–39.1]). Logistic regression (using data from PAP users) showed a positive association of PAP adherence with satisfaction with PAP (OR [95% CI]: 5.43 [3.73–7.90]); OSA treatment effectiveness (3.56 [2.48–5.12]); OSA symptom management (3.15 [2.17–4.57]); coordination of OSA care (2.60 [1.82–3.72]); and education from their healthcare provider on the impact of OSA on cardiovascular health (1.62 [1.13–2.35]), importance of using PAP (1.7 [1.15–2.52]), or availability of prescription drugs to treat OSA symptoms (1.55 [1.06–2.26]). The presence of EDS was associated with lower patient satisfaction in nearly all domains examined (ORs ranged from 0.44–0.62 across 6 of 7 domains). EDS was common in this real-world population with OSA, even among participants who were highly adherent PAP users. PAP adherence was associated with higher patient satisfaction across all care domains; the presence of EDS was associated with lower patient satisfaction across 6 of 7 domains. Jazz Pharmaceuticals
- 25 May 2022
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 45 (Supplement) , A331
Open Access0760 Excessive daytime sleepiness, positive airway pressure, and patient satisfaction with multiple aspects of care in a real-world population with obstructive sleep apnea
Excessive daytime sleepiness (EDS) is common in patients with obstructive sleep apnea (OSA) and can persist despite use of positive airway pressure (PAP) therapy. These analyses assessed relationships between EDS, PAP use, and patient satisfaction across several aspects of OSA care in a real-world population with OSA. US residents (aged ≥18 years, self-reported physician OSA diagnosis [1/1/2015–3/31/2020]) completed a survey in Evidation Health’s Achievement app assessing Epworth Sleepiness Scale (ESS), PAP usage, and satisfaction with care. Self-reported PAP use was categorized as nonuse, nonadherent (<4 h/night; 10). PAP use was: nonuse (n=700), nonadherent (n=153), or adherent (n=1436; intermediate n=225, high n=1211). Within these subgroups, the proportions (95% CI) with EDS were: nonuse (47% [43.7–51.1]), nonadherent (52% [44.4–60.2]), intermediate (53% [46.4–59.4]), and highly adherent (36% [33.7–39.1]). Logistic regression (using data from PAP users) showed a positive association of PAP adherence with satisfaction with PAP (OR [95% CI]: 5.43 [3.73–7.90]); OSA treatment effectiveness (3.56 [2.48–5.12]); OSA symptom management (3.15 [2.17–4.57]); coordination of OSA care (2.60 [1.82–3.72]); and education from their healthcare provider on the impact of OSA on cardiovascular health (1.62 [1.13–2.35]), importance of using PAP (1.7 [1.15–2.52]), or availability of prescription drugs to treat OSA symptoms (1.55 [1.06–2.26]). The presence of EDS was associated with lower patient satisfaction in nearly all domains examined (ORs ranged from 0.44–0.62 across 6 of 7 domains). EDS was common in this real-world population with OSA, even among participants who were highly adherent PAP users. PAP adherence was associated with higher patient satisfaction across all care domains; the presence of EDS was associated with lower patient satisfaction across 6 of 7 domains. Jazz Pharmaceuticals
- 1 November 2021
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 97, 104506
Corrigendum to ‘Frailty and heart response to physical activity’ [Archives of Gerontology and Geriatrics 93 (2021) 104323]
- 1 November 2021
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 97, 104506
Corrigendum to ‘Frailty and heart response to physical activity’ [Archives of Gerontology and Geriatrics 93 (2021) 104323]